G. Schlimok

624 total citations
16 papers, 351 citations indexed

About

G. Schlimok is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, G. Schlimok has authored 16 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in G. Schlimok's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers) and Genetic factors in colorectal cancer (2 papers). G. Schlimok is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers) and Genetic factors in colorectal cancer (2 papers). G. Schlimok collaborates with scholars based in Germany, United States and Austria. G. Schlimok's co-authors include G. Riethmüller, Sepp Braun, Lutz Riethdorf, G. Eric Schaller, Klaus Pantel, W. Ehret, A. Wischnik, Arnold Ganser, Ralf Schulze and Michael Lübbert and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal of Cancer.

In The Last Decade

G. Schlimok

15 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Schlimok Germany 9 209 117 110 97 48 16 351
J Witte Netherlands 8 147 0.7× 220 1.9× 129 1.2× 99 1.0× 20 0.4× 11 359
Hui‐Jen Tsai Taiwan 10 207 1.0× 84 0.7× 48 0.4× 135 1.4× 20 0.4× 16 425
Tina Nuebling Germany 9 247 1.2× 45 0.4× 106 1.0× 132 1.4× 14 0.3× 13 455
Sven Tyge Langkjer Denmark 9 365 1.7× 118 1.0× 55 0.5× 72 0.7× 32 0.7× 27 446
Robert H. Gersh United States 7 151 0.7× 43 0.4× 206 1.9× 190 2.0× 33 0.7× 8 501
Gretchen Taylor United States 8 322 1.5× 118 1.0× 42 0.4× 145 1.5× 17 0.4× 11 503
Sarah E. Dorff United States 4 177 0.8× 60 0.5× 56 0.5× 117 1.2× 20 0.4× 5 364
Jing Lai China 14 241 1.2× 116 1.0× 158 1.4× 178 1.8× 24 0.5× 38 571
Bühring Hj Germany 7 138 0.7× 38 0.3× 281 2.6× 211 2.2× 41 0.9× 12 538
Junichiro Yuda Japan 10 268 1.3× 43 0.4× 180 1.6× 198 2.0× 31 0.6× 43 566

Countries citing papers authored by G. Schlimok

Since Specialization
Citations

This map shows the geographic impact of G. Schlimok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schlimok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schlimok more than expected).

Fields of papers citing papers by G. Schlimok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Schlimok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schlimok. The network helps show where G. Schlimok may publish in the future.

Co-authorship network of co-authors of G. Schlimok

This figure shows the co-authorship network connecting the top 25 collaborators of G. Schlimok. A scholar is included among the top collaborators of G. Schlimok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Schlimok. G. Schlimok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Wagner, Katharina, Frédérik Damm, Felicitas Thol, et al.. (2012). Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia. Blood. 120(21). 1381–1381. 2 indexed citations
4.
Märkl, Bruno, H Arnholdt, Hendrik Jähnig, et al.. (2010). Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer. Human Pathology. 41(7). 1024–1033. 23 indexed citations
5.
Schalhorn, Andreas, D. Quietzsch, P. Maubach, et al.. (2005). Phase III trial of irinotecan plus oxaliplatin (IROX) versus irinotecan plus 5-FU/folinic acid (FOLFIRI) as first-line treatment of metastatic colorectal cancer (CRC): The FIRE-Trial. Journal of Clinical Oncology. 23(16_suppl). 3516–3516. 11 indexed citations
6.
Braun, Sepp, G. Schlimok, G. Eric Schaller, et al.. (2001). ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.. PubMed. 61(5). 1890–5. 151 indexed citations
7.
Krauter, J, Arnold Ganser, Lothar Bergmann, et al.. (1999). Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML. Annals of Hematology. 78(6). 265–269. 13 indexed citations
8.
Krauter, Jürgen, Wolfgang Peter, Ulrich Pascheberg, et al.. (1998). Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML. British Journal of Haematology. 103(1). 72–78. 48 indexed citations
9.
Schulze, Ralf, et al.. (1997). Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplantation. 19(12). 1223–1228. 48 indexed citations
10.
Funk, E. M., G. Schlimok, W. Ehret, & J. Witte. (1997). [The current status of vaccination and antibiotic prophylaxis in splenectomy. I: Adults].. PubMed. 68(6). 586–90. 1 indexed citations
11.
Riethmüller, G., G. Schlimok, W. Schmiegel, et al.. (1995). Monoclonal antibody (MAB) treatment of resected Dukes C colorectal carcinoma (CRC): A prospective randomized trial. European Journal of Cancer. 31. S14–S14. 2 indexed citations
12.
Winkelmann, M., K Ebeling, G Strohmeyer, et al.. (1992). Treatment results of the thioether lipid ilmofosine in patients with malignant tumours. Journal of Cancer Research and Clinical Oncology. 118(6). 405–407. 13 indexed citations
13.
Link, Hartmut, M. Freund, H. Diedrich, et al.. (1990). Mitoxantrone, Cytosine Arabinoside, and VP-16 in 36 Patients with Relapsed and Refractory Acute Myeloid Leukemia. Hämatologie und Bluttransfusion. 33. 322–325. 10 indexed citations
14.
Pfadenhauer, K. & G. Schlimok. (1990). [Leptomeningeal carcinosis--new diagnostic possibilities by tumor cell marking with monoclonal antibodies].. PubMed. 61(4). 228–30. 1 indexed citations
15.
Schlimok, G., et al.. (1989). [Bone marrow micrometastases in colorectal cancers].. PubMed. 107(2). 59–63. 4 indexed citations
16.
Krawietz, W., et al.. (1988). [Surgical aortic valve replacement for acute Streptococcus viridans endocarditis with simultaneous moderate hemophilia A].. PubMed. 77(7). 470–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Witte Breakdown of academic impact, for papers by Hui‐Jen Tsai Breakdown of academic impact, for papers by Tina Nuebling Breakdown of academic impact, for papers by Sven Tyge Langkjer Breakdown of academic impact, for papers by Robert H. Gersh Breakdown of academic impact, for papers by Gretchen Taylor Breakdown of academic impact, for papers by Sarah E. Dorff Breakdown of academic impact, for papers by Jing Lai Breakdown of academic impact, for papers by Bühring Hj Breakdown of academic impact, for papers by Junichiro Yuda
Rankless by CCL
2026